Stroke

Showing NaN - NaN of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endovascular Intervention for STroke Existing Disability

Not yet recruiting
  • Stroke
  • +2 more
  • Endovascular Stroke Treatment
  • Medical Management
  • Phoenix, Arizona
  • +11 more
Jun 20, 2023

Stroke Trial in Worldwide (Sentinel® Cerebral Protection System)

Completed
  • Stroke
  • Sentinel® Cerebral Protection System
  • Tucson, Arizona
  • +56 more
Jan 17, 2023

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage

Enrolling by invitation
  • Intra Cerebral Hemorrhage
  • +11 more
    • Birmingham, Alabama
    • +25 more
    Jan 19, 2023

    Cardiovascular Disease, Myocardial Infarction, Stroke Trial (Evolocumab, Routine Lipid Management)

    Recruiting
    • Cardiovascular Disease
    • +3 more
    • Fairhope, Alabama
    • +14 more
    Dec 21, 2022

    Stroke, Patent Foramen Ovale Trial in Canada, United States (Investigational PFO Closure Device, Standard of Care PFO Closure

    Enrolling by invitation
    • Stroke
    • Patent Foramen Ovale
    • Investigational PFO Closure Device
    • Standard of Care PFO Closure Device
    • Stanford, California
    • +11 more
    Dec 5, 2022

    Atrial Fibrillation, Stroke Trial in United States (CLAAS, WATCHMAN left atrial appendage closure device / Amulet left atrial

    Enrolling by invitation
    • Atrial Fibrillation
    • Stroke
    • CLAAS
    • WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
    • Birmingham, Alabama
    • +5 more
    Aug 16, 2022

    Peri-device Leakage Closure After LAAO

    Completed
    • Atrial Fibrillation
    • +3 more
    • Peri-device leakage closure after left atrial appendage occlusion
    • Phoenix, Arizona
    • +15 more
    Jul 20, 2022

    Stroke Prevention in Young Adults With Sickle Cell Anemia

    Active, not recruiting
    • Sickle Cell Disease
    • +5 more
    • Hydroxyurea therapy per standard care
    • Nashville, Tennessee
    • +1 more
    Jul 13, 2022

    Stroke Trial in Worldwide (Amulet Left Atrial Appendage Occluder, WATCHMAN Left Atrial Appendage Closure)

    Active, not recruiting
    • Stroke
    • Amulet Left Atrial Appendage Occluder
    • WATCHMAN Left Atrial Appendage Closure
    • Huntsville, Alabama
    • +114 more
    Jul 8, 2022

    Stroke, PFO - Patent Foramen Ovale Trial in United States (PFO closure with GORE® CARDIOFORM Septal Occluder)

    Recruiting
    • Stroke
    • PFO - Patent Foramen Ovale
    • PFO closure with GORE® CARDIOFORM Septal Occluder
    • La Jolla, California
    • +38 more
    Jun 6, 2022

    Sickle Cell Disease, Stroke, Neurologic Manifestations Trial in Nashville, Kano (This study does not entail offering any

    Active, not recruiting
    • Sickle Cell Disease
    • +5 more
    • This study does not entail offering any intervention; all data collected will be based on standard of care.
    • Nashville, Tennessee
    • +2 more
    Apr 14, 2022

    Stroke Trial in Canada, United States (Apixaban, Aspirin)

    Recruiting
    • Stroke
    • Birmingham, Alabama
    • +181 more
    Mar 26, 2022

    Stroke, Hypertension Trial in Nashville (Technological Facilitator, Standard of Care)

    Withdrawn
    • Stroke
    • Hypertension
    • Technological Facilitator
    • Standard of Care
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Mar 4, 2022

    Thromboembolism, Hemolysis, Stroke Trial in United States (Lavare On, Lavare Off)

    Terminated
    • Thromboembolism
    • +2 more
    • Lavare On
    • Lavare Off
    • Birmingham, Alabama
    • +3 more
    Jan 13, 2022

    Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

    Completed
    • Stroke
    • +2 more
    • Birmingham, Alabama
    • +182 more
    Apr 14, 2020

    Stroke, Secondary Prevention Trial in Worldwide (optional ASA as comedication, to ASA, to optional ASA as comedication)

    Completed
    • Stroke
    • Secondary Prevention
    • optional ASA as comedication
    • +5 more
    • Phoenix, Arizona
    • +568 more
    Aug 13, 2019

    Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (Botulinum Toxin Type A)

    Completed
    • Pediatrics
    • +3 more
    • Botulinum Toxin Type A
    • Pasadena, California
    • +47 more
    Jul 29, 2019

    Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

    Completed
    • Atrial Fibrillation
    • Stroke
    • Birmingham, Alabama
    • +983 more
    Apr 8, 2019

    Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

    Completed
    • Stroke
    • +2 more
    • warfarin tablets
    • +4 more
    • Birmingham, Alabama
    • +1015 more
    Feb 8, 2019

    Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

    Terminated
    • Stroke
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +3 more
    • Tucson, Arizona
    • +453 more
    Dec 20, 2018

    Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (botulinum toxin Type A, Normal Saline (Placebo))

    Completed
    • Pediatrics
    • +3 more
    • botulinum toxin Type A
    • Normal Saline (Placebo)
    • Pasadena, California
    • +44 more
    Jul 16, 2018

    Atrial Fibrillation, Stroke Trial in United States (WATCHMAN Device, Warfarin)

    Completed
    • Atrial Fibrillation
    • Stroke
    • Gilbert, Arizona
    • +40 more
    Jul 25, 2018

    Stroke Trial in Canada, United States (Tissue plasminogen activator (Activase®))

    Terminated
    • Stroke
    • Tissue plasminogen activator (Activase®)
    • Palo Alto, California
    • +14 more
    Apr 26, 2018

    Impact of Neuromonitoring During Cardiac Procedures

    Completed
    • Delirium
    • +2 more
      • Nashville, Tennessee
        Vanderbilt University School of Medicine
      Mar 13, 2018

      Hemodynamic Compensation in Patients With Intracranial Stenosis

      Completed
      • Stroke
      • Intracranial Stenosis
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Jan 23, 2018